The MedBiquitous Consortium is launching a new project called MEMS 2.0 that it hopes will offer a streamlined, efficient, and effective system for collecting data about continuing healthcare education provided in accordance with the FDA’s extended-release and long-acting opioid analgesics Risk Evaluation and Mitigation Strategy, known as ER/LA REMS. At the core of ER/LA REMS is a requirement to educate ER/LA opioid analgesics prescribers on how to safely and effectively prescribe ...

Register for Complete Access (Valid Email Required)

By registering on MeetingsNet now, you'll not only unlock the MedBiquitous Launches Project to Support FDA REMS Initiative, you'll also gain access to exclusive premium content.

Already registered? here.